Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable performance history. They are often considered less risky and are a popular choice for long-term investors. Additionally,…
Wages cover the bills. Dividends buy back your time. Earned income stops when you do; portfolio income deposits into your brokerage account on a fixed schedule set by a board of directors,…
Market volatility has rattled portfolios in 2026, with broad equity indexes absorbing sharp swings tied to tariff uncertainty and shifting rate expectations. For investors who have watched their growth positions whipsaw, the…
A $500,000 retirement portfolio spread across five income-focused stocks can generate a blended yield of roughly 7.4%, translating to about $37,000 per year in dividends. That’s about $3,083 per month—a chunk of…
AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net sales with revenue up 10% year over year, powered by a…
Pre-Market Stock Futures: The futures are trading modestly higher after a wild Wednesday that saw the Nasdaq explode higher to close at an all-time high of 24,016, up a hefty 1.60%, while…
Two million dollars spread across four household-name dividend payers can generate over $120,000 in annual income. That is the income profile of the moderate yield tier, where Enterprise Products Partners L.P. (NYSE:EPD),…
A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it do. At a blended yield of roughly 6%, $1,000,000 produces exactly $60,000…
Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two very different pharmaceutical stories. AbbVie is riding a post-Humira reinvention, while Pfizer…
VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of betting on a single drug pipeline. Right now, that diversification is being…
Pfizer (NYSE: PFE | PFE Price Prediction) is one of the most widely held dividend stocks among retirement investors. The stock currently yields 6.3%, well above most fixed-income alternatives. But a high…
Trey Thoelcke It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer (NYSE:PFE | PFE Price Prediction) have faced immense challenges in the years…
Joey Frenette Pfizer (NYSE:PFE | PFE Price Prediction) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over the past year. The stock is currently trading near $26.84 but remains…
Joel South After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing. My tenure at these premier Wall Street firms exposed…
Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open on the non-farm payrolls print that blew away estimates, despite a significant…
